Ontology highlight
ABSTRACT: Background
Over 350 million people worldwide are infected with hepatitis B virus (HBV), a major cause of liver failure and hepatocellular carcinoma. Current therapeutic agents are highly effective, but are also associated with development of viral resistance. Therefore, strategies for identifying other anti-HBV agents with specific, but distinctive mechanisms of action are needed. The human La (hLa) protein, which forms a stabilizing complex with HBV RNA ribonucleoprotein to promote HBV replication, is a promising target of molecular therapy.Aims
This study aimed to discover novel inhibitors of hLa that could inhibit HBV replication and expression.Methods
A multistage molecular docking approach was used to screen a Specs database and an in-house library against hLa
SUBMITTER: Tang J
PROVIDER: S-EPMC3338670 | biostudies-literature | 2012
REPOSITORIES: biostudies-literature